ProShares UltraShort NASDAQ Biotechnology
6 hedge funds and large institutions have $1.08M invested in ProShares UltraShort NASDAQ Biotechnology in 2024 Q4 according to their latest regulatory filings, with 0 funds opening new positions, 2 increasing their positions, 2 reducing their positions, and 1 closing their positions.
Holders
6
Holders Change
-1
Holders Change %
-14.29%
% of All Funds
0.08%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
2
Reduced
2
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
1
Jane Street
New York
|
$704K |
| 2 |
2
Morgan Stanley
New York
|
$1.37K |
| Name | Market Value | Shares |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
1
Jane Street
New York
| $704K | 38,696 | +28,176 | +268% |
|
2
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| $275K | 15,114 | -15,784 | -51% |
|
|
TRCT
3
Tower Research Capital (TRC)
New York
| $96.8K | 5,321 | -10,110 | -66% |
|
4
Citigroup
New York
| $1.55K | 85 | – | – |
|
|
5
Morgan Stanley
New York
| $1.37K | 75 | +1 | +1% |
|
6
UBS Group
Zurich,
Switzerland
| $18 | 1 | – | – |
|
|
PIS
7
POM Investment Strategies
Raleigh,
North Carolina
| – | – | -5 | Closed |
|
|
CFGS
8
Concourse Financial Group Securities
Birmingham,
Alabama
| – | – | – | – |
|